Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Cotter

Showing results (161-170 of 290) with videos related to

Pageof 29
Sort By:
European Journal of Heart Failure|June 16, 2025
Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot studyNicolas Girerd, Jan Biegus, Adam Janas, et al.
European Journal of Heart Failure|May 22, 2016
Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)Karen Sliwa, Albertino Damasceno, Beth A Davison, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
European Journal of Heart Failure|March 7, 2020
Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trialSatit Janwanishstaporn, Siting Feng, John Teerlink, et al.
Journal of the American College of Cardiology|March 19, 2013
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failurePeter van der Meer, Douwe Postmus, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
European Heart Journal|March 11, 2011
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMarco Metra, Christopher M O'Connor, Beth A Davison, et al.
Pageof 29

Showing results (161-170 of 290) with videos related to

Sort By:
Pageof 29
European Journal of Heart Failure|June 16, 2025
Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot studyNicolas Girerd, Jan Biegus, Adam Janas, et al.
European Journal of Heart Failure|May 22, 2016
Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)Karen Sliwa, Albertino Damasceno, Beth A Davison, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
European Journal of Heart Failure|March 7, 2020
Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trialSatit Janwanishstaporn, Siting Feng, John Teerlink, et al.
Journal of the American College of Cardiology|March 19, 2013
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failurePeter van der Meer, Douwe Postmus, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
European Heart Journal|March 11, 2011
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMarco Metra, Christopher M O'Connor, Beth A Davison, et al.
Pageof 29